Terms: = Liver cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
210 results:
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
2. Tumor cell-derived LC3B
Chen YQ; Man ZS; Zheng L; Zhang Y; Zhao CW; Ma YT; Zhou J; Wang P; Yu Y; Gu F; Niu GP
Clin Immunol; 2024 Apr; 261():109925. PubMed ID: 38310993
[TBL] [Abstract] [Full Text] [Related]
3. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
[TBL] [Abstract] [Full Text] [Related]
4. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK
J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055
[TBL] [Abstract] [Full Text] [Related]
5. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
[TBL] [Abstract] [Full Text] [Related]
6. Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma.
Li Z; Wang Y; Xing R; Zeng H; Yu XJ; Zhang YJ; Xu J; Zheng L
Cancer Immunol Res; 2023 Oct; 11(10):1400-1413. PubMed ID: 37467346
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues.
Chatterjee A; Chaudhary A; Ghosh A; Arun P; Mukherjee G; Arun I; Maitra A; Biswas N; Majumder PP
Cancer Med; 2023 Aug; 12(16):16774-16787. PubMed ID: 37392167
[TBL] [Abstract] [Full Text] [Related]
8. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract] [Full Text] [Related]
9. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma.
Liu Y; Chen X; Luo W; Zhao Y; Nashan B; Huang L; Yuan X
Cancer Med; 2023 Aug; 12(15):16370-16385. PubMed ID: 37326143
[TBL] [Abstract] [Full Text] [Related]
10. Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma.
Yagi K; Shimada S; Akiyama Y; Hatano M; Asano D; Ishikawa Y; Ueda H; Watanabe S; Akahoshi K; Ono H; Tanabe M; Tanaka S
Sci Rep; 2023 Jun; 13(1):9449. PubMed ID: 37296228
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptomic evidence for tumor-specific beneficial or adverse effects of TGFβ pathway inhibition on the prognosis of patients with liver cancer.
Desoteux M; Maillot B; Bévant K; Ferlier T; Leroux R; Angenard G; Louis C; Sulpice L; Boudjema K; Coulouarn C
FEBS Open Bio; 2023 Jul; 13(7):1278-1290. PubMed ID: 37195148
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
Ortiz-Barahona V; Soler M; Davalos V; García-Prieto CA; Janin M; Setien F; Fernández-Rebollo I; Bech-Serra JJ; De La Torre C; Guil S; Villanueva A; Zhang PH; Yang L; Guarnacci M; Schumann U; Preiss T; Balaseviciute U; Montal R; Llovet JM; Esteller M
Mol Cancer; 2023 May; 22(1):83. PubMed ID: 37173708
[TBL] [Abstract] [Full Text] [Related]
13. CD204⁺ tumor-associated macrophages are associated with clinical outcome in canine pulmonary adenocarcinoma and transitional cell carcinoma.
Yokota S; Kaji K; Yonezawa T; Momoi Y; Maeda S
Vet J; 2023; 296-297():105992. PubMed ID: 37164121
[TBL] [Abstract] [Full Text] [Related]
14. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
15. Aberrantly Expressed MicroRNAs in cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
[TBL] [Abstract] [Full Text] [Related]
16. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in liver cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract] [Full Text] [Related]
17. Sea Cucumber Derived Triterpenoid Glycoside Frondoside A: A Potential Anti-Bladder cancer Drug.
Ru R; Chen G; Liang X; Cao X; Yuan L; Meng M
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678249
[TBL] [Abstract] [Full Text] [Related]
18. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association.
El-Sheikh NM; Abulsoud AI; Wasfey EF; Hamdy NM
Pathol Res Pract; 2022 Dec; 240():154183. PubMed ID: 36327824
[TBL] [Abstract] [Full Text] [Related]
19. Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis.
Salpini R; D'Anna S; Piermatteo L; Svicher V
J Viral Hepat; 2022 Dec; 29(12):1038-1047. PubMed ID: 36256499
[TBL] [Abstract] [Full Text] [Related]
20. Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma.
Yang YB; Wu CY; Wang XY; Deng J; Cao WJ; Tang YZ; Wan CC; Chen ZT; Zhan WY; Shan H; Kuang DM; Wei Y
Mol Ther; 2023 Jan; 31(1):105-118. PubMed ID: 36183166
[TBL] [Abstract] [Full Text] [Related]
[Next]
